
Kairos Pharma to Present at DealFlow Discovery Conference as Oncology Programs Advance
Kairos Pharma's participation in the DealFlow Discovery Conference highlights investor engagement opportunities as the company advances its clinical-stage oncology programs targeting drug resistance mechanisms in cancer treatment.
Read full story























